My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 2 66 /


Post-genomic clinical trials: the perspective of ACGT

Advancing Clinico Genomic Trials (ACGT) is an EU co-funded project that develops open-source semantic and grid-based technologies in support of post genomic clinical trials in cancer research. It addresses clinicians bio-researchers as well as software developers providing an open platform where novel and powerful services can be offered and put to use by practitioners in the field.

This article discusses the ACGT's approach to collecting and dealing with genomic data. It also looks at the ACGT's ultimate objective providing a unified technological infrastructure which will facilitate the seamless and secure access and analysis of multi-level clinical and genomic data enriched with high-performing knowledge discovery operations and services.

By doing so it is expected that the influence of genetic variation in oncogenesis will be revealed the molecular classification of cancer and the development of individualised therapies will be promoted and finally the in-silico tumour growth and therapy response will be realistically and reliably modelled.



Loading Article Metrics ... Please wait

Related articles

Research: Men seeking counselling in a Breast Cancer Risk Evaluation Clinic

Abstract | Full Article | PDF Published: 30 Jan 2018 /

Review: A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Abstract | Full Article | PDF Published: 25 Jan 2018 /

Conference Report: Highlights from the Inaugural International Cancer Microbiome Consortium Meeting (ICMC), 5–6 September 2017, London, UK

Abstract | Full Article | PDF Published: 20 Dec 2017 /

Research: Limitations of workers diagnosed with cancer evaluated with Work Role Functioning Questionnaire-Br

Abstract | Full Article | PDF | Portuguese Published: 18 Sep 2017 /

Review: Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer

Abstract | Full Article | PDF Published: 18 Sep 2017 /

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence